Amylin (20-29) (human)

Modify Date: 2024-01-10 19:41:50

Amylin (20-29) (human) Structure
Amylin (20-29) (human) structure
Common Name Amylin (20-29) (human)
CAS Number 118068-30-7 Molecular Weight 1009.07
Density N/A Boiling Point N/A
Molecular Formula C43H68N12O16 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Amylin (20-29) (human)


Amylin (20-29) (human) is the fragment of human islet amyloid polypeptide (hIAPP) or Amylin. Amylin is a 37-residue hormone. Amylin (20-29) (human) is responsible for the amyloidogenic propensities of the full length protein. Amylin (20-29) (human) can be transformed into its corresponding peptoid and retropeptoid sequences, to obtain beta-sheet breaker peptides as amyloid inhibitors[1][2].

 Names

Name h-ser-asn-asn-phe-gly-ala-ile-leu-ser-ser-oh
Synonym More Synonyms

 Amylin (20-29) (human) Biological Activity

Description Amylin (20-29) (human) is the fragment of human islet amyloid polypeptide (hIAPP) or Amylin. Amylin is a 37-residue hormone. Amylin (20-29) (human) is responsible for the amyloidogenic propensities of the full length protein. Amylin (20-29) (human) can be transformed into its corresponding peptoid and retropeptoid sequences, to obtain beta-sheet breaker peptides as amyloid inhibitors[1][2].
Related Catalog
References

[1]. Kapurniotu A, et al. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity. J Mol Biol. 2002 Jan 18;315(3):339-50.  

[2]. Elgersma RC, et al. Transformation of the amyloidogenic peptide amylin(20-29) into its corresponding peptoid and retropeptoid: access to both an amyloid inhibitor and template for self-assembled supramolecular tapes. Bioorg Med Chem Lett. 2007 Apr 1;17(7):1837-42.  

 Chemical & Physical Properties

Molecular Formula C43H68N12O16
Molecular Weight 1009.07
Exact Mass 1008.49000
PSA 472.09000

 Safety Information

Safety Phrases 22-24/25
WGK Germany 3

 Synonyms

AMYLIN FRAGMENT 20-29 HUMAN
SER-ASN-ASN-PHE-GLY-ALA-ILE-LEU-SER-SER
diabetes associated peptide fragment 20-29 human
SNNFGAILSS